Article info

Download PDFPDF
Aducanumab for Alzheimer’s disease: expediting approval and delaying science

Authors

  1. Correspondence to Dr Rodrigo A. Salinas, Departamento de Ciencias Neurológicas, Universidad de Chile, Santiago de Chile, RM 7500922, Chile; salinasra{at}gmail.com
View Full Text

Citation

Salinas RA
Aducanumab for Alzheimer’s disease: expediting approval and delaying science

Publication history

  • Accepted June 21, 2021
  • First published July 14, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.